Advertisement
Advertisement
January 17, 2011
Covidien Launches Next-Generation EverFlex+ Peripheral Stent System in Europe
January 18, 2011—Covidien (Mansfield, MA) announced the European launch of the EverFlex+ nitinol self-expanding peripheral stent system for the treatment of peripheral arterial disease.
According to the company, the EverFlex+ is intended to treat the superficial femoral artery (SFA) and proximal popliteal lesions. The device is designed to reduce the risk of fracture when elongated, improving clinical outcomes. The next-generation system offers the radial strength and flexibility of the current EverFlex system, with additional durability in a highly flexible platform, representing a significant advance in nitinol self-expanding stent technology. The EverFlex was launched worldwide in March 2006 for treating peripheral arterial disease and stenting for the SFA.
Advertisement
Advertisement